NCT03590574 2026-03-16Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell LymphomaAutolus LimitedPhase 1/2 Terminated20 enrolled 34 charts
NCT06761677 2026-02-05A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell LymphomaSymBio PharmaceuticalsPhase 1/2 Suspended43 enrolled
NCT06035497 2025-05-14A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)Bristol-Myers SquibbPhase 1/2 Recruiting85 enrolled
NCT02273739 2021-02-23Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 MutationCelgenePhase 1/2 Completed21 enrolled 33 charts
NCT02742727 2016-12-06CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and LymphomaPersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1/2 Unknown10 enrolled